Medical News

RSS

Study examines potential health benefits of DCT

Imagine your delight while enjoying your favorite Mexican food - perhaps a fully loaded bean burrito topped with an ample supply of thinly sliced jalepeño peppers. What happens when you bite into a few more peppers than you bargained for? Does this thought conjure up the thought of a little heat? Perhaps even a bit of sweat on the brow? Indeed, food scientists can tell you that hot peppers contain a substance called capsaicin that not only adds spice to our foods but can actually cause your body to heat up.

28 Apr 2010

Takeda settles with six defendants in generic ACTOS, ACTOplus met patent infringement lawsuit

Takeda Pharmaceutical Company Limited announced today that Takeda and its wholly owned subsidiary, Takeda Pharmaceuticals North America, Inc., have completed settlement agreements with six out of eight defendants in patent infringement litigation brought against these parties in response to their Abbreviated New Drug Applications for generic ACTOS® (pioglitazone HCl) and ACTOplus met® (pioglitazone HCl and metformin HCl). Takeda recently concluded litigation with the sixth settling defendant.

28 Apr 2010

Rare neuroscience looks at how strong identification with racial group affects empathy

Race matters on a neurological level when it comes to empathy for African-Americans in distress, according to a new Northwestern University study.

28 Apr 2010

Researchers find Alzheimer's pathology to originate from Amyloid-Beta oligomers in the brain

Using a new mouse model of Alzheimer's disease, researchers at Mount Sinai School of Medicine have found that Alzheimer's pathology originates in Amyloid-Beta (Abeta) oligomers in the brain, rather than the amyloid plaques previously thought by many researchers to cause the disease.

28 Apr 2010

Study evaluates cost benefits of new interventions for treating, preventing PDN and PHN

Constantly rising U.S. health care costs could be reduced significantly by preventing and treating neuropathic pain conditions associated with diabetes and herpes zoster virus infections, according to research published in The Journal of Pain, the peer review publication of the American Pain Society, www.ampainsoc.org and jpain.org.

28 Apr 2010

GE Healthcare joins TRIL Centre as second industry partner

The TRIL (Technology Research for Independent Living) Centre, Ireland is delighted to announce a new industry partner, GE Healthcare. TRIL is a groundbreaking research initiative, founded in January 2007 by Intel Corporation and the IDA Ireland (Industrial Development Agency), to explore the physical, cognitive and social consequences of ageing and design technologies to help address them. The addition of GE Healthcare as an industry partner will help TRIL to extend and expand its research programme.

28 Apr 2010

FXR can slow proliferation of tamoxifen-resistant breast cancer cells: Study

A receptor that is present in the nucleus of cells can, when activated, slow the growth of tamoxifen-resistant breast cancer cells, a new study found. The study built on the recent discovery that farnesoid X receptor — a nuclear receptor found mainly in the liver — is found in breast cancer tissue.

28 Apr 2010

Study finds kids five and younger dangerously physically inactive

According to the 2010 Active Healthy Kids Canada Report Card on Physical Activity for Children and Youth, Canadian kids five and younger are dangerously physically inactive. Healthy habits must start young, as lifestyle patterns set in the early years predict obesity and health outcomes in later childhood, and even through adulthood.

28 Apr 2010

Loyola University Health System to appreciate volunteers for making hats, blankets for cancer patients

In a special blessing ceremony Loyola University Health System will say "thank you" to volunteers from local parishes who have donated their time and talents to make comfort items such as hats and blankets for cancer patients at the Cardinal Bernardin Cancer Center.

28 Apr 2010

AAP testimony asks CDC DOH to include periodontal surveillance as part of strategic priorities

The American Academy of Periodontology was recently invited to provide testimony to the Centers for Disease Control and Prevention's Division of Oral Health as part of the strategic planning process for 2011 through 2014.

28 Apr 2010

AHF applauds Merck for doubling Isentress discount rebates and freezing price for ADAPs

Following an innovative, years long advocacy campaign spearheaded by AIDS Healthcare Foundation (AHF) that targeted Merck and Co. Pharmaceuticals over the pricing of its AIDS drug Isentress—one of the most expensive first line AIDS therapies on the US market today—officials from AHF lauded Merck today for significant concessions that the drug giant is putting in place on its pricing and rebate policies for the nation's AIDS Drug Assistance Programs (ADAP), the federally funded, state run programs that supply lifesaving AIDS drugs to low-income Americans in need.

28 Apr 2010

High dose B-vitamin therapy slows progression of diabetic nephropathy: Study

Patients with diabetic nephropathy (kidney disease caused by diabetes) who received high dose B-vitamin therapy experienced a more rapid decline in kidney function and had a higher rate of heart attack and stroke than patients who received placebo, according to a study in the April 28 issue of JAMA.

28 Apr 2010

Kaiser Permanente approves over 250 grants and donations totaling $7 million

Kaiser Permanente, one of America's leading health care providers and nonprofit health plans, announced today it approved more than 250 grants and donations nationwide totaling approximately $7 million in the first quarter of 2010. The grants focused on expanding access to nutritious food, providing safe spaces for all ages to increase physical activity, increasing opportunities for continuing education, and eliminating health disparities.

28 Apr 2010

Cancer-related expenditures increase faster than any other area of health care: JAMA

From 1999 through 2006 the use of diagnostic imaging for Medicare patients with cancer increased, with use of positron emission tomography increasing the most significantly, according to a study in the April 28 issue of JAMA. Imaging costs for these patients also increased, outpacing the rate of increase in total costs among Medicare beneficiaries with cancer.

28 Apr 2010

CTI receives positive reception from EMEA clinical experts for pixantrone MAA

Cell Therapeutics, Inc. today reported recent accomplishments and financial results for the first quarter ended March 31, 2010.

28 Apr 2010

Top ten tips for managing healthcare

America's healthcare system is about to undergo the most fundamental transformation in our nation's history. An already over-stressed system must absorb 32 million new patients at the same time that the country's huge baby boomer population is likely to need ever more medical attention as they age. And many of our most experienced and talented physicians will soon reach retirement age, leaving fewer experienced doctors to treat more patients.

28 Apr 2010

Study examines world-wide use of HSCT

An examination of the world-wide use of hematopoietic stem cell transplantation, which involves transplantation of blood stem cells derived from the bone marrow or blood, finds that there are significant differences in transplant rates between countries and continental regions by indication and donor type, and that HSCT is most frequently used in countries with higher gross national incomes and governmental health care expenditures, according to a study in the April 28 issue of JAMA.

28 Apr 2010

Potential new treatment for osteonecrosis

Researchers at Mount Sinai School of Medicine have found a potential new treatment for osteonecrosis, or the death of bone tissue, in people who are treated with steroids for several common medical conditions. There are currently no treatment options for people with this debilitating disease. The research is published in the April 27 issue of Proceedings of the National Academy of Sciences.

28 Apr 2010

BiondVax announces successful conclusion of second Phase I/II trial of Multimeric-001 Universal Flu Vaccine

BiondVax Pharmaceuticals Ltd., an Israeli biopharmaceutical company at the forefront of global efforts towards the development of a Universal Influenza Vaccine, announced the successful conclusion of the Company's second Phase I/II clinical trial of the Multimeric-001 Universal Influenza Vaccine.

28 Apr 2010

IMB awards manufacturer licenses to PPD’s Athlone facility

PPD, Inc. today announced its contract research facility in Athlone, Ireland, has been awarded manufacturer licenses by the Irish Medicines Board. The licenses support investigational medicinal products and marketed products and provide laboratory certifications for quality control of medicinal products.

28 Apr 2010

Medical News

Study examines potential health benefits of DCT

Takeda settles with six defendants in generic ACTOS, ACTOplus met patent infringement lawsuit

Rare neuroscience looks at how strong identification with racial group affects empathy

Researchers find Alzheimer's pathology to originate from Amyloid-Beta oligomers in the brain

Study evaluates cost benefits of new interventions for treating, preventing PDN and PHN

GE Healthcare joins TRIL Centre as second industry partner

FXR can slow proliferation of tamoxifen-resistant breast cancer cells: Study

Study finds kids five and younger dangerously physically inactive

Loyola University Health System to appreciate volunteers for making hats, blankets for cancer patients

AAP testimony asks CDC DOH to include periodontal surveillance as part of strategic priorities

AHF applauds Merck for doubling Isentress discount rebates and freezing price for ADAPs

High dose B-vitamin therapy slows progression of diabetic nephropathy: Study

Kaiser Permanente approves over 250 grants and donations totaling $7 million

Cancer-related expenditures increase faster than any other area of health care: JAMA

CTI receives positive reception from EMEA clinical experts for pixantrone MAA

Top ten tips for managing healthcare

Study examines world-wide use of HSCT

Potential new treatment for osteonecrosis

BiondVax announces successful conclusion of second Phase I/II trial of Multimeric-001 Universal Flu Vaccine

IMB awards manufacturer licenses to PPD’s Athlone facility

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News